Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
Background: The treatment of lower grade gliomas (LGG) is currently the most challenging dilemma in the management of intracranial tumors. Necroptosis is a type of programmed cell death that is closely associated with tumor progression, However, the role of necroptosis related genes in LGG is not ye...
Main Authors: | Xiqi Hu, Yanan Ma, Ying Xia, Bo Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023111558 |
Similar Items
-
Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
by: Ruofei Liang, et al.
Published: (2023-09-01) -
Dabrafenib plus Trametinib: A breakthrough in pediatric low‐grade glioma therapy
by: Marrium Sultan Dar, et al.
Published: (2024-01-01) -
Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes
by: Ahsan Ali Khan, et al.
Published: (2024-07-01) -
Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma
by: Yongze He, et al.
Published: (2022-12-01) -
Thioredoxin related transmembrane protein 1acts as a prognostic indictor and promotes proliferation and TMZ resistance of lower-grade glioma
by: Hongyan Hui, et al.
Published: (2025-02-01)